Soligenix
SNGX
#11002
Rank
NZ$13.03 M
Marketcap
NZ$0.60
Share price
0.51%
Change (1 day)
-75.22%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2026 (TTM): -NZ$20.01 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$21.19 Million a decrease over its 2024 earnings that were of -NZ$16.72 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$20.01 Million-5.58%
2025 -NZ$21.19 Million26.72%
2024 -NZ$16.72 Million22.96%
2023 -NZ$13.6 Million-45.74%
2022 -NZ$25.06 Million11.88%
2021 -NZ$22.4 Million-32.37%
2020 -NZ$33.11 Million83.18%
2019 -NZ$18.08 Million11.57%
2018 -NZ$16.2 Million19.29%
2017 -NZ$13.58 Million33%
2016 -NZ$10.21 Million-19.7%
2015 -NZ$12.72 Million5.16%
2014 -NZ$12.1 Million
2010 -NZ$13.65 Million26.12%
2009 -NZ$10.83 Million75.1%
2008 -NZ$6.18 Million-45.38%
2007 -NZ$11.32 Million-22.84%
2006 -NZ$14.67 Million66.15%
2005 -NZ$8.83 Million-16.65%
2004 -NZ$10.59 Million13.28%
2003 -NZ$9.35 Million-11.88%
2002 -NZ$10.61 Million-59.44%
2001 -NZ$26.16 Million378.18%
2000 -NZ$5.47 Million-38.53%
1999 -NZ$8.9 Million-18.43%
1998 -NZ$10.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$33.47 B-160,056.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$12.35 B-59,115.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$12.80 B-61,279.19%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-NZ$32.47 Million 55.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-NZ$74.68 Million 256.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.87 B-13,813.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-NZ$4.93 Million-76.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-NZ$0.18 Billion 712.56%๐Ÿ‡บ๐Ÿ‡ธ USA